Meet EPDA vice-president Susanna Lindvall as she gets involved in #UniteForParkinsons 2018
Author: Almaz OhenePublished: 8 March 2018
Prep: Cook: Serves:
On International Women’s Day, Susanna Lindvall, vice president of the European Parkinson’s Disease Association (EPDA), shares her hopes for #UniteForParkinsons 2018 – and explains why more female-focused research into Parkinson’s is essential
Today is International Women’s Day and we’re also only a few weeks away from World Parkinson’s Day, which is when the #UniteForParkinsons campaign hopes to hit new heights. Tell us about the campaign and how the EPDA is getting involved.
We have been working very hard for the past few months generating support and interest from all of our global network. Our aim is for Parkinson’s organisations and supporters around the world to be inspired to come together on a bigger scale than ever to show what Parkinson’s truly is.
At the EPDA, we believe this will only actually happen if we start working together as an international community in a real and tangible way. That’s what World Parkinson’s Day is all about and that’s why we created the #UniteForParkinsons campaign with Parkinson’s UK last year.
So, can you tell us about your role at the EPDA and describe your typical day as a board member?
I am very interested in research, so on a typical day I begin by answering email questions relating to Parkinson’s studies and research. I have telephone conference meetings with pharmaceutical companies and I’m in contact with Parkinson’s professionals throughout Europe. I also do some writing for the Swedish Parkinson’s magazine.
What changes to Parkinson’s diagnosis and treatment have you seen during your time working within the sector?
If we look at the diagnosis process, nowadays there are studies ongoing in biomarkers providing early diagnosis including imaging techniques, cerebral spinal fluid analysis and changes in the retina in the eyes.
In terms of treatment, I am very happy that clinicians recognise that a lot of younger people can have Parkinson’s. I am also glad that non-motor symptoms such as anxiety, depression and physical pain are also a recognised part of the disease.
We now have a wide range of drugs and treatments such as oral drugs, deep brain stimulation, medication patches and intestinal gels for continuous intestinal administration, and neurologists have begun to see the importance of exercise in slowing the progression of the disease.
What are your hopes for Parkinson’s treatments in the next few years? And in the long term?
I’d like more studies to be carried out that focus on gender in Parkinson’s disease and the differences regarding progression of the condition. The gender-specific approach is very important and it’s necessary to pay special attention to the predictors that cause poor health and poor quality of life. At present, we don’t have a general understanding of the differences.
In many Parkinson’s studies, there aren’t any women included in the data. I think we need many more women participating so that we can learn how the progression of the disease in women compares with that in men. We will then also learn how Parkinson’s medications affect women’s and men’s bodies differently.
What are you most excited about in terms of Parkinson’s developments: will we see a cure in your lifetime?
My hopes regarding treatments in the next five years are that we will find ways to detect the condition in its very early stages. At the same time, we need neuroprotective drugs. A combination of these two factors would be great.
(L–R) Susanna Lindvall, Sara Riggare and Eli Pollard at the EPDA’s European Unity Walk, 2012
What is your personal connection to Parkinson’s disease?
My mother had Parkinson’s, and my father was a doctor who took care of my mother for several years. Then gradually I got more and more involved in her care and treatment. Another close family member who had Parkinson’s for several years suffered from hallucinations. He was living alone and did not dare to go into the bedroom to change clothes and go to bed in the evening, because he thought he was seeing people in there listening to him. This went on for a long time before we realised what was happening. When we finally found out, we took him to the neurologist to change his medication. Everything became much better for him after that.
Is there an experience you’ve had with Parkinson’s, either personally or professionally, that has given you hope?
Yes, for me research gives me hope. Because if you are looking at the exponential increase in the amount of research being carried out, all the ongoing studies and publications, for me it says that it has to result in a major breakthrough. When I see healthcare professionals and people with Parkinson’s share positive experiences and good models of care that improve quality of life – which is of vital importance – this also gives me hope.
What do you hope the campaign will achieve this year and in the future?
We really need the international Parkinson’s community – and by that I mean individuals, families, charities, healthcare professionals, decision makers and commercial companies from all over the world – supporting #UniteForParkinsons and getting involved. Last year it was a hashtag, this year it’s the hashtag and videos. Next year, who knows? What I do know is that from an EPDA perspective, we can’t make change happen on our own. But if we work together, then in theory anything is possible. And that’s what the #UniteForParkinsons campaign is all about.
Susanna has been the vice-president of the European Parkinson’s Disease Association (EPDA) since 2005. She was born in Romania but has lived in Sweden since 1962, where she gained a BSc in organic chemistry from the University of Stockholm. From 1996 to 2002 she was president of ParkinsonFörbundet, the Swedish Parkinson’s Disease Association (SPA). She worked for many years as an information specialist at dairy company Arla Foods until her retirement in 2010.
The EPDA and Parkinson’s UK are running the #UniteForParkinsons campaign to coincide with World Parkinson’s Day on 11 April. Get involved on the day by making your own Parkinson’s video and sharing it on social media using the hashtag. For more information, visit the website. Campaign toolkits are available to download in English, French, German, Italian, Spanish and Welsh. A Dutch version will also soon be available.
How New York inspired Copenhagen to walk for Parkinson’s
‘Exercise is medicine’: the Danish Parkinson’s Association’s motto
1 day ago
Sir Billy Connolly: Parkinson’s disease is “like a strange animal”
Scottish comedian, actor and musician Sir Billy Connolly has recently discussed his experience of Parkinson’s disease while promoting his new autobiography, ‘Windswept & Interesting’. In an appearance on UK talk show, ‘The Graham Norton Show’, the comedian explained that he had lost the ability to write. He said: “It breaks my heart as I used to love writing letters to people.” Speaking to UK newspaper The Guardian, Connolly added that he thinks the condition is “like a strange animal. One that sits beside you and says, ‘How will you get on without this?’ – before it takes away something else.” Despite these adjustments, Connolly told Norton he has “good days and bad days” with the condition. “It’s creeping up on me and it never lets go,” he said. “I walk like a drunk man and have to have help. So, life is different, but it is good.” Lead image credit:…
New insights on immune cell process and Parkinson’s disease
Insoluble clumps of the protein alpha-synuclein, which can cause damage to brain cells, have been previously linked to Parkinson’s. Now, scientists in Germany, France and the US have uncovered new details on how brain cells respond to these clusters. The researchers discovered that the brain’s immune cells may be able to join together to break down the protein clumps. According to a press release, this was previously unknown. They also found that these neighbouring cells share mitochondria – structures that generate energy for chemical reactions – to help one another. In certain mutations associated with Parkinson’s, this process may be impaired. The researchers hope this insight could inform the development of new therapies. “We have opened the door to a field that will certainly engage researchers for many years to come,” said Professor Dr Michael Heneka, director of the Department of Neurodegenerative Diseases and Geriatric Psychiatry at the University Hospital…
Could analysing skin oil help diagnose Parkinson’s disease?
Parkinson’s disease patients tend to have high levels of oil, known as sebum, on their skin’s surface. Now, a study has suggested that analysing this substance may help when diagnosing the condition. The study revealed that sebum contains significant amounts of genetic material, specifically the molecule ribonucleic acid (RNA). Analysis of RNA contained in sebum – that is, skin surface lipids RNA, or SSL-RNA – could offer insights into a person’s health. Researchers in Japan examined SSL-RNA in men and women with and without Parkinson’s. The results suggested that the SSL-RNA profiles of those with Parkinson’s had “different characteristics” than those without. The researchers then tested whether examining these profiles with machine learning could reveal those who had Parkinson’s – and who didn’t. The team’s algorithm indicated a “relatively robust discriminatory ability,” supporting the further use of SSL-RNA as part of a future “non-invasive” method for diagnosis.